You are here

Structural & Congenital Heart Disease

 

The self-expanding Centera transcatheter heart valve has received CE mark approval, device manufacturer Edwards Lifesciences announced Feb. 15.

Survivors of childhood heart defects are more likely than the general population to develop dementia, including at earlier ages, researchers reported Feb. 12 in Circulation.

US News & World Report issued their rankings for the top 10 hospitals for pediatric cardiology and heart surgery in the country.

New research published in the Journal of the American Medical Association suggests a patent foramen ovale (PFO), colloquially known as a hole in the heart, can double the risk of stroke within 30 days of non-cardiac surgery.

The LOTUS Edge Aortic Valve System will not be available in Europe or the U.S. until at least 2019, Boston Scientific CEO Mike Mahoney said during a Feb. 1 conference call with investors.

 

Recent Headlines

Time of year, day of week could influence incidence of MI

New research suggests that certain times of year or days of the week could have an effect on the incidence of myocardial infarction (MI).

FDA, health orgs encourage better ways to test heart drugs in children

In a new health policy statement, the U.S. Food and Drug Administration (FDA) and other major health organizations have called for improvements in the way medications are developed and tested in children with heart disease.

Making the Call for Closure: Heart–Brain Teams Strive to Improve Patient Selection for PFO Closure

Did the patent foramen ovale (PFO) cause the patient’s stroke? This, experts say, is the key question when deciding whether to recommend PFO closure. Heart–brain teams can help with the answer.   

A Practical Guide to Palliative Care for Heart Failure Patients

With a few practical steps, cardiology practices can meet the palliative care needs of heart failure patients.     

Healing hearts, one molecule at a time

We cut a finger and the skin heals. But what if hearts could heal too? Researchers recently found a molecule in newborns that might help, some day. The team at the Weizmann Institute of Science have identified a molecule found in newborns that appears to control the renewal process, assisting regeneration in damaged hearts.

Scientists ID cell that can regenerate heart tissue after MI

Researchers at the Weizmann Institute of Science in Israel have uncovered a molecule found in newborns that aids in regenerating damaged hearts—and are now testing ways that the molecule could treat heart attack victims.

Amgen seeks market approval for Repatha in U.S., Europe

Thousand Oaks, California-based Amgen has submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration (FDA) and a variation of one in Europe seeking approval for Repatha, a PCSK9 inhibitor.

Liver disease more prominent in Fontan surgery patients, research shows

New research from the Children’s Hospital of Philadelphia shows patients who have undergone the Fontan operation as children are at an increased risk for developing progressive liver fibrosis.

Chemotherapy-induced cardiomyopathy hits men harder than women

A small study examining how chemotherapy-induced cardiomyopathy found that men experienced greater side effects, including significantly lower left and right ventricular ejection.

New research clarifies why we think moderate drinking is heart healthy

We’ve all heard that a glass of wine could be good for your heart, but new evidence from research at the University of Victoria in British Columbia, Canada, says otherwise.

Pages